Glucagon-like receptor 1 agonists and DPP-4 inhibitors: potential therapies for the treatment of stroke

During the past decades, candidate drugs that have shown neuroprotective efficacy in the preclinical setting have failed in clinical stroke trials. As a result, no treatment for stroke based on neuroprotection is available today. The activation of the glucagon-like peptide 1 receptor (GLP-1) for red...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Cereb Blood Flow Metab
Main Authors: Darsalia, Vladimer, Larsson, Martin, Nathanson, David, Klein, Thomas, Nyström, Thomas, Patrone, Cesare
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2015
Assuntos:
Mini Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4420864/
https://ncbi.nlm.nih.gov/pubmed/25669907
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/jcbfm.2015.17
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados